Asia
Asia Pharmaceuticals & Healthcare Insight provides country-by-country analysis of the key trends impacting the prescription, OTC and generic drugs industries across Asia. Asia Pharmaceuticals & Healthcare Insight includes competitive intelligence on the growth strategies of leading national and multinational companies, along with 5-year industry forecasts for each country. The service includes access to the very latest analysis, a searchable archive of articles and data and the ability to download PDFs of current and back issues.
›› To gain FREE online access for 14 days and to download a FREE PDF, click trial.
›› To receive 15 monthly pdf issues for the price of 12 and to gain immediate online access, click subscribe.
Japan / Industry
BMI View: Astellas performed well in fiscal 9M11, with net income increasing by nearly a third. We believe the company could expand its business in the emerging markets to build upon its growing Japanese operation, where it currently generates more than half of its global
2012-02-03Japan / Industry
BMI View: Japan's medical device market is an attractive proposition to local and foreign companies. Sales have grown consistently over the past decade and we forecast sustained expansion...
2012-01-23South Korea / Industry
BMI View: BMI's view on the liberalisation of South Korea's over-the-counter (OTC) sector is playing out as the government will allow the sale of OTC drugs in convenience stores. We...
2012-01-03Industry Developments
Japan
BMI View: Astellas performed well in fiscal 9M11, with net income increasing by nearly a third. We believe the company could expand its business in the emerging markets to build upon...
2012-02-03Japan
BMI View: Japan's medical device market is an attractive proposition to local and foreign companies. Sales have grown consistently over the past decade and we forecast sustained expansion...
2012-01-23South Korea
BMI View: BMI's view on the liberalisation of South Korea's over-the-counter (OTC) sector is playing out as the government will allow the sale of OTC drugs in convenience stores. We...
2012-01-03Sri Lanka
BMI View: While it is clear that the implementation of a medicine pricing policy will work towards controlling public pharmaceuticals and healthcare expenditure, we believe that it...
2011-12-14
